Purple Biotech

purple-biotech.comRehovot, IsraelMember of Connectively Wire since
Releases
1
First release
Most recent
Categories
Nasdaq:PPBT

Press releases from Purple Biotech

1 release

  1. Nasdaq:PPBT

    Purple Biotech's IM1240, a CAPTN-3-Capped Tri-Specific T- and NK-Cell Engager Targeting 5T4, Shows Robust Tumor Killing in Immunotherapy-Resistant Cancer Models in Plenary Oral Presentation at EORTC-NCI-AACR Symposium

    Plenary oral presentation by Mount Sinai immunologist Dr. Amir Horowitz highlights Purple Biotech's CAPTN-3 platform of capped tri-specific antibodies, designed to engage T cells and NK cells against cancers expressing antigens of interest while overcoming inhibitory signals…